Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

NCT05269485 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.

NCT05044728 ·Status: UNKNOWN ·Phase: PHASE2

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

NCT04821765 ·Status: COMPLETED ·Phase: PHASE2

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

NCT01667302 ·Status: UNKNOWN ·Phase: PHASE2

Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer

NCT04522687 ·Status: RECRUITING

A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)

NCT00886678 ·Status: UNKNOWN ·Phase: PHASE2

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

NCT03432598 ·Status: COMPLETED ·Phase: PHASE2

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

NCT06692062 ·Status: RECRUITING ·Phase: NA

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

NCT05348668 ·Status: COMPLETED ·Phase: PHASE2

The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor

NCT06311968 ·Status: RECRUITING ·Phase: PHASE2

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

NCT07187908 ·Status: RECRUITING ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous Non-small Cell Lung Cancer

NCT03663205 ·Status: COMPLETED ·Phase: PHASE3

Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC

NCT04405674 ·Status: UNKNOWN ·Phase: PHASE2

Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors

NCT02636556 ·Status: COMPLETED ·Phase: NA

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

NCT04947774 ·Status: UNKNOWN

Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC

NCT02455843 ·Status: UNKNOWN ·Phase: PHASE3

Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors

NCT04517539 ·Status: UNKNOWN ·Phase: PHASE2

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors

NCT06013111 ·Status: RECRUITING ·Phase: PHASE1

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma

NCT02460419 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma

NCT01536223 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC

NCT04982549 ·Status: UNKNOWN ·Phase: PHASE2

SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC

NCT05652192 ·Status: RECRUITING ·Phase: PHASE2

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)

NCT00817583 ·Status: UNKNOWN ·Phase: PHASE2

The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors

NCT02031731 ·Status: COMPLETED ·Phase: PHASE1